Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with a manufacturing facility in Kvistgård, and an additional site in Hørsholm.[3] The company has a research and development facility in Martinsried, Germany, and offices in Zug, Switzerland, and Morrisville, North Carolina. The company uses viral vectors in its research and development.
^"Archive.ph". Archived from the original on 2022-03-13. Retrieved 2023-09-08.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
^"OMX Copenhagen 25 (OMXC25CAP)" (PDF). Nasdaq OMX. Archived from the original (PDF) on 13 March 2022.
^ ab"Hellerup, Denmark". Bavarian Nordic. Archived from the original on March 13, 2022. Retrieved 6 December 2021.
^"Board of Directors". BN. Retrieved 2024-04-08.
^"Executive Management". BN. Archived from the original on 2020-07-17. Retrieved 2024-04-08.
^"Annual Report 2023" (PDF). Bavarian Nordic. Archived from the original (PDF) on April 2, 2024. Retrieved April 8, 2024.
BavarianNordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company...
Into the Strategic" (Press release). Retrieved 4 July 2022. BavarianNordic. "BavarianNordic Announces U.S. FDA Approval of Jynneos (Smallpox and Monkeypox...
1 July 2020. Retrieved 16 July 2020 – via Reuters. BavarianNordic (15 July 2015). "BavarianNordic announces that the Oxford Vaccines Group has initiated...
developed by Expres2ion Biotechnologies and Adaptvac, outlicensed to BavarianNordic. On 9 August 2021, it was announced that the first round of trials...
commercialise PROSTVAC, BavarianNordic's phase III prostate-specific antigen targeting cancer immunotherapy. BavarianNordic would receive an upfront...
vaccine, RabAvert, and its tick-borne encephalitis vaccine, Encepur, to BavarianNordic for US$1.06 billion (€955 million). In July 2020, GSK acquired a 10%...
top-tier stock market index for Nasdaq Copenhagen, which is part of the Nasdaq Nordic, prior being replaced (as of December 2017) was known as OMX Copenhagen...
Nasdaq Copenhagen, based in Copenhagen. Many of these companies have secondary listings on other stock exchanges. Stocks: Nasdaq OMX Nordic, 20 2024-01-07...
glafolivec) is a cancer immunotherapy candidate in clinical development by BavarianNordic for the treatment of all prostate cancer although clinical trials are...
vaccine was further developed and manufactured by the Danish company BavarianNordic, resulting in the vaccine MVA-BN, which is unable to replicate in human...
included vaccines by GSK, Pfizer, Johnson & Johnson, Moderna, and BavarianNordic. As of April 2023[update], other vaccines were in development, including...
donors include Open Philanthropy, Smith Richardson Foundation, and BavarianNordic. The Bipartisan Commission on Biodefense is co-chaired by former Senator...
Technologies Incorporation, Elusys Therapeutics, DynPort Vaccine Company LLC, BavarianNordic and Nanotherapeutics Incorporation. During the 115th Congress in July...
the European Commission was developed by Janssen Pharmaceutials and BavarianNordic, and utilizes MVA technology in its second vaccine dose of Mvabea (MVA-BN-Filo)...
the medical and health fields and include: AcelRx Pharmaceuticals, BavarianNordic, Codexis, Genomic Health, Guardant Health, Gynesonics, Minerva Surgical...
the following biotechnology companies and university research labs: BavarianNordic Baxter International BioCryst iBio / CC-Pharming (former) Chimerix...
The Baiuvarii, Bavarii, or Bavarians (German: Bajuwaren) were a Germanic people. The Baiuvarii had settled in modern-day Bavaria (which is named after...
Global Information
7.062 billion kr. (2023)